Cargando…

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the most common complications of type 2 diabetes mellitus (T2DM). The pathogenesis of NAFLD involves multiple biological changes, including insulin resistance, oxidative stress, inflammation, as well as genetic and environmental factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Tingli, Yan, Wenhui, Cui, Xin, Liu, Na, Wei, Xiaotong, Sun, Yuzhuo, Fan, KeXin, Liu, Jieyun, Zhu, Yuanyuan, Wang, Zhuanzhuan, Zhang, Yilei, Chen, Lina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540362/ https://www.ncbi.nlm.nih.gov/pubmed/37770820 http://dx.doi.org/10.1186/s10020-023-00721-7

Ejemplares similares

Erythropoietin Mitigates Diabetic Nephropathy by Restoring PINK1/Parkin-Mediated Mitophagy
por: Yi, Xinyao, et al.
Publicado: (2022)

Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice
por: Song, Ji-Xian, et al.
Publicado: (2022)

Liraglutide attenuates the osteoblastic differentiation of MC3T3-E1 cells by modulating AMPK/mTOR signaling
por: Hu, Xiong-Ke, et al.
Publicado: (2016)

Metformin attenuates diabetic renal injury via the AMPK-autophagy axis
por: Sun, Tingli, et al.
Publicado: (2021)

Energy stress-mediated AMPK activation inhibits ferroptosis
por: Lee, Hyemin, et al.
Publicado: (2020)

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway
por: Yu, Peng, et al.
Publicado: (2019)

High-Dosage NMN Promotes Ferroptosis to Suppress Lung Adenocarcinoma Growth through the NAM-Mediated SIRT1–AMPK–ACC Pathway
por: Zhang, Mingjiong, et al.
Publicado: (2023)

Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis‐related NLRP3 pathway
por: Song, Shuang, et al.
Publicado: (2022)

Liraglutide reduces fatty degeneration in hepatic cells via the AMPK/SREBP1 pathway
por: WANG, YAN-GUI, et al.
Publicado: (2015)

STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway
por: Zhang, Yichao, et al.
Publicado: (2022)

LKB1-AMPK axis negatively regulates ferroptosis by inhibiting fatty acid synthesis
por: Li, Changzhi, et al.
Publicado: (2020)

Alisol A attenuates high‐fat‐diet‐induced obesity and metabolic disorders via the AMPK/ACC/SREBP‐1c pathway
por: Ho, Chiakang, et al.
Publicado: (2019)

Loss of Lactate/Proton Monocarboxylate Transporter 4 Induces Ferroptosis via the AMPK/ACC Pathway and Inhibition of Autophagy on Human Bladder Cancer 5637 Cell Line
por: Dong, Siqi, et al.
Publicado: (2023)

Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway
por: Zhang, Wanqiu, et al.
Publicado: (2023)

Fatty Acids Regulate Porcine Reproductive and Respiratory Syndrome Virus Infection via the AMPK-ACC1 Signaling Pathway
por: Long, Siwen, et al.
Publicado: (2019)

Role of the AMPK/ACC Signaling Pathway in TRPP2-Mediated Head and Neck Cancer Cell Proliferation
por: Li, Kun, et al.
Publicado: (2020)

CPI-613 rewires lipid metabolism to enhance pancreatic cancer apoptosis via the AMPK-ACC signaling
por: Gao, Lixia, et al.
Publicado: (2020)

High Fat Activates O-GlcNAcylation and Affects AMPK/ACC Pathway to Regulate Lipid Metabolism
por: Pang, Yuning, et al.
Publicado: (2021)

Controlled release of liraglutide using thermogelling polymers in treatment of diabetes
por: Chen, Yipei, et al.
Publicado: (2016)

TQFL12, a novel synthetic derivative of TQ, inhibits triple‐negative breast cancer metastasis and invasion through activating AMPK/ACC pathway
por: Wei, Chunli, et al.
Publicado: (2021)

The emerging roles of MAPK-AMPK in ferroptosis regulatory network
por: Wang, Xinyue, et al.
Publicado: (2023)

The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
por: Andreozzi, Francesco, et al.
Publicado: (2016)

Hypolipogenic Effect of Shikimic Acid Via Inhibition of MID1IP1 and Phosphorylation of AMPK/ACC
por: Kim, Moon Joon, et al.
Publicado: (2019)

Deep Sea Water Modulates Blood Pressure and Exhibits Hypolipidemic Effects via the AMPK-ACC Pathway: An in Vivo Study
por: Sheu, Ming-Jyh, et al.
Publicado: (2013)

Liraglutide Attenuates Hepatic Ischemia–Reperfusion Injury by Modulating Macrophage Polarization
por: Li, Shang-Lin, et al.
Publicado: (2022)

Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway
por: Xu, Xiaotian, et al.
Publicado: (2017)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

PFKP alleviates glucose starvation-induced metabolic stress in lung cancer cells via AMPK-ACC2 dependent fatty acid oxidation
por: Chen, Jiaqing, et al.
Publicado: (2022)

Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression
por: Shao, Yimin, et al.
Publicado: (2015)

Plasmodium Infection Induces Dyslipidemia and a Hepatic Lipogenic State in the Host through the Inhibition of the AMPK-ACC Pathway
por: Kluck, George Eduardo Gabriel, et al.
Publicado: (2019)

Galanin ameliorates liver inflammation and fibrosis in mice by activating AMPK/ACC signaling and modifying macrophage inflammatory phenotype
por: He, Lingnan, et al.
Publicado: (2023)

Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway
por: Li, Sichen, et al.
Publicado: (2020)

Dapagliflozin, Liraglutide, and Their Combination Attenuate Diabetes Mellitus-Associated Hepato-Renal Injury—Insight into Oxidative Injury/Inflammation/Apoptosis Modulation
por: El-Sherbiny, Mohamed, et al.
Publicado: (2022)

Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
por: Yang, Mengying, et al.
Publicado: (2020)

Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
por: Tian, Feng, et al.
Publicado: (2018)

Efficacy and Clinical Value of Liraglutide for Treatment of Diabetes Mellitus Complicated by Non-Alcoholic Fatty Liver Disease
por: Zhang, Zhongyong, et al.
Publicado: (2018)

Liraglutide reduces oxidized LDL-induced oxidative stress and fatty degeneration in Raw 264.7 cells involving the AMPK/SREBP1 pathway
por: Wang, Yan-Gui, et al.
Publicado: (2015)

Ethylene, ACC, and the Plant Growth-Promoting Enzyme ACC Deaminase
por: Gamalero, Elisa, et al.
Publicado: (2023)

Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling
por: Zhang, Zhe, et al.
Publicado: (2021)

Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits
por: Pan, Chun-Hsu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7esvj0f84bbm80klqun69iujpg